Finding accredited CPD

Systemic Treatment in Prostate & Renal Cancers


Prostate and renal cancer therapy is a highly individualised treatment regimen. There are several treatment modalities used to treat these cancers affectively. These can also have a significant impact on co-morbidities and be highly problematic in general practice.

Join Dr Tania Moujaber, Medical Oncologist, as she outlines the wide range of treatments used for prostate and renal cancers, and how best to identify and manage side effects that may appear in general practice.

Learning Outcomes

  1. Review the incidence and prevalence of prostate cancer in the community
  2. Discuss the pharmacology of current single and multi-therapies used in prostate cancer treatment
  3. Review the incidence and prevalence of renal cell carcinoma (RCC) in the community
  4. Discuss the pharmacology of current single and multi-therapies used in RCC treatment
  5. Discuss the impact of side effects related to pharmaceutical therapies on patients' quality of life and how to manage in the community with prostatic and RCC.



Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.

Upon completion, your CPD activity record may take up to 4 weeks to be reflected on your CPD Home Dashboard.

CPD Activity Details
Educational Activities
General Learning
Course / module
CPD Hours
6h : 30m
General Practice and Primary Care, Urology, Oncology
Medical practitioners
Applicable CAPE Aspects

You have to log in to see the content of this module.

Provided by

Accredited by